KURA Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates as Pipeline Development Intensifies KOD Q1 2026 Earnings Narrower Loss on Lower Spending as Pipeline Progress Continues HURA Q1 2026 Earnings Narrow Loss Wider Than Expected Stock Gains on Pipeline Progress Penumbra PEN Q1 2026 Earnings EPS Misses Estimates by 245 as Revenue Details Remain Unclear Insperity Q1 2026 Earnings EPS Beat Drives Strong Stock Reaction LEG Q1 2026 Earnings EPS Misses Estimates by 3724 Despite Positive Stock Reaction